JP2008535493A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535493A5
JP2008535493A5 JP2008505602A JP2008505602A JP2008535493A5 JP 2008535493 A5 JP2008535493 A5 JP 2008535493A5 JP 2008505602 A JP2008505602 A JP 2008505602A JP 2008505602 A JP2008505602 A JP 2008505602A JP 2008535493 A5 JP2008535493 A5 JP 2008535493A5
Authority
JP
Japan
Prior art keywords
dendritic cells
rna
monocytes
ratio
mature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008505602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008535493A (ja
JP5020935B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/013159 external-priority patent/WO2006127150A2/en
Publication of JP2008535493A publication Critical patent/JP2008535493A/ja
Publication of JP2008535493A5 publication Critical patent/JP2008535493A5/ja
Application granted granted Critical
Publication of JP5020935B2 publication Critical patent/JP5020935B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008505602A 2005-04-08 2006-04-07 樹状細胞組成物および方法 Expired - Fee Related JP5020935B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66946805P 2005-04-08 2005-04-08
US60/669,468 2005-04-08
PCT/US2006/013159 WO2006127150A2 (en) 2005-04-08 2006-04-07 Dendritic cell compositions and methods

Publications (3)

Publication Number Publication Date
JP2008535493A JP2008535493A (ja) 2008-09-04
JP2008535493A5 true JP2008535493A5 (cg-RX-API-DMAC7.html) 2009-05-28
JP5020935B2 JP5020935B2 (ja) 2012-09-05

Family

ID=36992670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008505602A Expired - Fee Related JP5020935B2 (ja) 2005-04-08 2006-04-07 樹状細胞組成物および方法

Country Status (12)

Country Link
US (6) USRE46152E1 (cg-RX-API-DMAC7.html)
EP (1) EP1882031B1 (cg-RX-API-DMAC7.html)
JP (1) JP5020935B2 (cg-RX-API-DMAC7.html)
KR (6) KR20170086700A (cg-RX-API-DMAC7.html)
CN (1) CN101155914B (cg-RX-API-DMAC7.html)
AU (1) AU2006249640C1 (cg-RX-API-DMAC7.html)
CA (1) CA2602434C (cg-RX-API-DMAC7.html)
ES (1) ES2650569T3 (cg-RX-API-DMAC7.html)
IL (2) IL185977A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007012221A (cg-RX-API-DMAC7.html)
NO (1) NO345353B1 (cg-RX-API-DMAC7.html)
WO (1) WO2006127150A2 (cg-RX-API-DMAC7.html)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8513008B2 (en) 2004-10-07 2013-08-20 Argos Therapeutics, Inc. Mature dendritic cell compositions and methods for culturing same
WO2007065439A1 (en) * 2005-12-08 2007-06-14 Dandrit Biotech A/S Method for generating dendritic cells employing decreased temperature
AU2007238660C1 (en) 2006-04-14 2013-11-07 Astellas Institute For Regenerative Medicine Hemangio-colony forming cells
US8877206B2 (en) 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
US8524495B2 (en) 2007-05-16 2013-09-03 Yale University Methods for inducing the differentiation of blood monocytes into functional dendritic cells
KR100935826B1 (ko) 2007-11-27 2010-01-08 주식회사 바이넥스 부유밀도구배 원심분리를 이용하여 말초혈액단핵구로부터 단세포를 분리하는 방법
US8513208B2 (en) 2008-02-28 2013-08-20 Argos Therapeutics, Inc. Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
WO2009120891A2 (en) * 2008-03-27 2009-10-01 Geron Corporation Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
AU2009236306B2 (en) 2008-04-17 2015-04-02 Pds Biotechnology Corporation Stimulation of an immune response by enantiomers of cationic lipids
KR20110081336A (ko) * 2008-11-04 2011-07-13 이데라 파마슈티칼즈, 인코포레이티드 안티센스 올리고누클레오티드에 의한 ｔｏｌｌ―유사 수용체 2 발현의 조절
WO2011032161A2 (en) 2009-09-14 2011-03-17 Baylor Research Institute Vaccines directed to langerhans cells
BR112012014104A2 (pt) * 2009-12-04 2016-07-05 Stem Cell & Regenerative Medicine International Inc método de geração de células destrutoras naturais e células dendríticas de hemangioblastos embrionários humanos derivados de células-tronco
JP2013522309A (ja) * 2010-03-15 2013-06-13 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 活性化した成熟樹状細胞を調製し保存するシステムおよび方法
DK2552410T3 (en) 2010-03-31 2019-02-18 Stabilitech Biopharma Ltd PROCEDURE FOR THE CONSERVATION OF ALUNADUVANCES AND VACCINES WITH ALUNADUVANCES
JP5869553B2 (ja) 2010-03-31 2016-02-24 スタビリテック リミテッド ウイルス粒子、ポリペプチド又は生体材料を安定化させる添加剤
WO2011121306A1 (en) 2010-03-31 2011-10-06 Stabilitech Ltd. Stabilisation of viral particles
US20130011438A1 (en) * 2011-07-05 2013-01-10 SOTIO a.s. Means And Methods For Active Cellular Immunotherapy Of Cancer By Using Tumor Cells Killed By High Hydrostatic Pressure and Dendritic Cells
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
PL2785359T3 (pl) 2011-11-30 2018-12-31 Astellas Institute For Regenerative Medicine Mezenchymalne komórki zrębowe i związane z nimi zastosowania
SG11201404570WA (en) * 2012-02-10 2014-11-27 Hakushinkouseikai Foundation Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine
EP2857498B1 (en) * 2012-05-31 2018-04-25 JW Creagene Inc. Composition for maturing dendritic cells, and method for preparing antigen-specific dendritic cells using same
US10286064B2 (en) 2012-06-15 2019-05-14 Pds Biotechnology Corporation Cationic lipid vaccine compositions and methods of use
CN104471059B (zh) 2012-07-12 2018-04-17 珠海横琴爱姆斯坦生物科技有限公司 人胚胎干细胞衍生的间充质样干细胞、方法及其应用
AU2013317805B2 (en) 2012-09-21 2018-07-26 Pds Biotechnology Corporation Improved vaccine compositions and methods of use
AU2014213009B2 (en) * 2013-02-01 2019-01-03 Kira Biotech Pty Limited Anti-CD83 antibodies and use thereof
TWI656839B (zh) * 2013-03-15 2019-04-21 健臻公司 高密度細胞儲存方法
ES2777304T3 (es) * 2014-02-21 2020-08-04 Colmmune Inc Células TSCM y métodos de uso
CN103948917A (zh) * 2014-04-02 2014-07-30 江苏和泽生物科技有限公司 树突状细胞疫苗的制备方法
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB201413665D0 (en) 2014-07-03 2014-09-17 Transimmune Ag And Yale University Method for obtaining globally activated monocytes
KR101518972B1 (ko) 2014-08-01 2015-05-18 제이더블유크레아젠 주식회사 수지상세포의 제조방법, 이에 의해 제조된 수지상세포 및 그 용도
EP3957173A1 (en) 2014-09-18 2022-02-23 Genzyme Corporation Ultra-high density cell banking methods
WO2016076428A1 (ja) 2014-11-14 2016-05-19 日本赤十字社 臍帯血および末梢血の凍結保存方法および凍結保存用溶液
WO2016179001A1 (en) * 2015-05-01 2016-11-10 Baylor College Of Medicine Methods for enhancing an immune response with a ctla-4 antagonist
CN107921063A (zh) * 2015-07-02 2018-04-17 普莱瓦克斯免疫肿瘤学公司 用于采用登革病毒与树突细胞的联合疗法的组合物及方法
US11612652B2 (en) * 2015-11-13 2023-03-28 Pds Biotechnology Corporation Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
JP6779616B2 (ja) * 2015-12-25 2020-11-04 富士ソフト株式会社 Ｎｋｔ細胞活性化医薬組成物、その製造方法、及び抗原提示細胞の保存方法
CN109715196A (zh) 2016-06-13 2019-05-03 转矩医疗股份有限公司 用于促进免疫细胞功能的组合物和方法
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
CA3074826A1 (en) 2017-09-05 2019-03-14 Torque Therapeutics, Inc. Therapeutic protein compositions and methods of making and using the same
JP2021502419A (ja) * 2017-11-07 2021-01-28 コイミューン インコーポレイテッド 樹状細胞治療のための方法および使用
TW201924722A (zh) 2017-12-05 2019-07-01 美商Ｐｄｓ生技公司 用於刺激第i型干擾素基因之方法及包含陽離子脂質的組合物
WO2019136155A1 (en) * 2018-01-08 2019-07-11 The Regents Of The University Of Michigan Aldh1 antigen-pulsed dendritic cells
WO2019196088A1 (en) 2018-04-13 2019-10-17 Syz Cell Therapy Co. Methods of obtaining tumor-specific t cell receptors
CA3106403A1 (en) 2018-07-15 2020-01-23 Enochian BioPharma, Inc. Methods and compositions using recombinant dendritic cells for cancer therapy
KR102159766B1 (ko) * 2018-11-12 2020-09-24 조선대학교산학협력단 홍조류추출물을 이용한 미성숙수지상세포 분화유도용 배지조성물 및 미성숙수지상세포 분화유도방법
JP2022525928A (ja) * 2019-03-21 2022-05-20 ガミダ セル リミテッド 併用療法における移植に適したｎｋ細胞画分の増殖及び増殖ｎｋ細胞画分の使用
CN114621921A (zh) * 2020-12-11 2022-06-14 深圳先进技术研究院 一种提取神经突触体的方法
CN117881794A (zh) * 2021-06-30 2024-04-12 诺瓦瑟拉姆株式会社 制备包含血中循环肿瘤细胞的试样的方法
CN113980901B (zh) * 2021-12-28 2022-06-17 上海惠盾因泰生物科技有限公司 一种制备高纯度的成熟人树突状细胞的方法及应用
EP4544028A4 (en) * 2022-06-24 2026-05-20 Lihpao Life Science Corp PROCESS FOR THE PRODUCTION OF MATURE DENDRITIC CELLS
US12642618B2 (en) * 2023-01-04 2026-06-02 Sheridan O'Neal Carriers for collecting biological samples

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7659119B2 (en) 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
KR20000022445A (ko) 1996-07-10 2000-04-25 크리스토퍼 엘. 와이트, 스코트 지. 홀퀴스트, 스티븐 엘. 말라스카 수상돌기 세포의 활성화 방법
US20050084966A1 (en) 1999-04-20 2005-04-21 Edelson Richard L. Methods for inducing the differentiation of blood monocytes into functional dendritic cells
WO2000062818A1 (en) 1999-04-20 2000-10-26 Richard Leslie Edelson Differentiation of monocytes into functional dendritic cells
US20050158856A1 (en) 1999-04-20 2005-07-21 Edelson Richard L. Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials
IT1312570B1 (it) * 1999-05-28 2002-04-22 Genera Spa Metodo per il traferimento di antigeni a cellule dendritiche.
DE10041515A1 (de) 2000-08-24 2002-03-14 Gerold Schuler Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen
EP1270732A1 (en) 2001-06-21 2003-01-02 Schuler, Gerold Improved transfection of eukaryontic cells with linear polynucleotides by electroporation
FR2833271B1 (fr) 2001-12-10 2004-09-17 Coletica Production de cellules dendritiques in vitro a partir de monocytes cd14+, pour notamment la realisation de modeles cellulaires et/ou tissulaires en suspension, en monocouches et tridimentionnels; utilisation de ces modeles
JP4567446B2 (ja) 2002-06-19 2010-10-20 ノースウエスト バイオセラピューティクス，インコーポレイティド 白血球富化のための平行流濾過デバイスおよび方法
EP1389480A1 (en) * 2002-08-14 2004-02-18 Mondobiotech Interferon SA Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation
US20060239962A1 (en) 2002-12-04 2006-10-26 Banchereau Jacques F Rapid one-step generation of antigen loaded dendritic cell vaccine from precursors
CN1264974C (zh) * 2003-01-17 2006-07-19 江西医学院 白血病细胞诱导生成树突状细胞的培养基及其培养方法与应用
ATE420946T1 (de) 2003-02-27 2009-01-15 Northwest Biotherapeutics Inc Erzeugung dendritischer zellen aus monozytischen dendritischen vorläuferzellen mit gm-csf ohne anwesenheit zusätzlicher zytokine
CA2577320C (en) 2004-09-14 2019-08-13 Argos Therapeutics, Inc. Strain-independent amplification of pathogens and vaccines thereto
US8513008B2 (en) * 2004-10-07 2013-08-20 Argos Therapeutics, Inc. Mature dendritic cell compositions and methods for culturing same
DE602005025005D1 (de) 2004-10-07 2011-01-05 Argos Therapeutics Inc Zusammensetzungen reifer dendritischer zellen und verfahren zu deren kultivierung

Similar Documents

Publication Publication Date Title
Nail et al. Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments
Specjalski et al. MicroRNAs: potential biomarkers and targets of therapy in allergic diseases?
Maynard et al. Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation
Zhang et al. Mesenchymal stem cells alleviate bacteria‐induced liver injury in mice by inducing regulatory dendritic cells
Wakkach et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo
Smyth et al. Micro RNA s affect dendritic cell function and phenotype
Nair et al. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation
Min et al. TGF-β-associated miR-27a inhibits dendritic cell-mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7
Wang et al. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T‐cell tolerance
Hodge et al. Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer
Kalantari et al. Generation of immunogenic and tolerogenic clinical-grade dendritic cells
Jelley‐Gibbs et al. Influencing the fates of CD4 T cells on the path to memory: lessons from influenza
JP2004536615A5 (cg-RX-API-DMAC7.html)
CA2602434A1 (en) Dendritic cell compositions and methods
Díaz‐Zúñiga et al. T‐lymphocyte phenotype and function triggered by Aggregatibacter actinomycetemcomitans is serotype‐dependent
Croci et al. Human dental pulp stem cells modulate cytokine production in vitro by peripheral blood mononuclear cells from coronavirus disease 2019 patients
Naoe et al. Bacillus Calmette‐Guérin‐pulsed dendritic cells stimulate natural killer T cells and γδT cells
Liu et al. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK)
Mao et al. IL‐37 Plays a Beneficial Role in Patients with Acute Coronary Syndrome
JP2010523141A5 (cg-RX-API-DMAC7.html)
Holmstrøm et al. Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy
Son et al. Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells
Angelina et al. Cannabinoid WIN55212‐2 impairs peanut‐allergic sensitization and promotes the generation of allergen‐specific regulatory T cells
Yu et al. CTLA4 silencing with siRNA promotes deviation of Th1/Th2 in chronic hepatitis B patients
IL258071A (en) Methods related to activated branch cell preparations and immunotherapeutic therapies for patients with advanced cancer